Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
Saved in:
Main Authors: | , , , |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_44b5cb8fc3674d1ea1465e607c73f6f6 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Zengying Liu |e author |
700 | 1 | 0 | |a Ningxin Zhang |e author |
700 | 1 | 0 | |a Bin Zhou |e author |
700 | 1 | 0 | |a Yan Xu |e author |
245 | 0 | 0 | |a Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy |
260 | |b Frontiers Media S.A., |c 2022-04-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2022.854593 | ||
546 | |a EN | ||
690 | |a microarray | ||
690 | |a bioinformatics analysis | ||
690 | |a differentially expressed genes | ||
690 | |a fold change | ||
690 | |a false discovery rate | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 13 (2022) | |
787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2022.854593/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/44b5cb8fc3674d1ea1465e607c73f6f6 |z Connect to this object online. |